Scientists are racing to create a vaccine for COVID-19 in less than one year. Cambridge, Massachusetts based biotechnology company, Moderna, Inc. and the National Institute of Allergy and Infectious Diseases have co-developed the vaccine known as mRNA-1273, which is now in Phase 3 clinical trials with 30,000 adult volunteers. For an update on the phase 3 trials, Newt is joined by Dr. Tal Zaks, Chief Medical Officer at Moderna.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Episode 1051: The End of a Fair Price — Lindsay Owens on How Companies Use Your Data to Charge You More
40:28

Episode 1050: The Midterms, 27 Days Out — McLaughlin and Sosnik on Who Will Control Congress
41:35

Episode 1049: The Exhausted Majority — Who Independents Really Are and Why They'll Decide 2026
35:24